Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
120M
-
Number of holders
-
351
-
Total 13F shares, excl. options
-
135M
-
Shares change
-
+3.62M
-
Total reported value, excl. options
-
$5.42B
-
Value change
-
+$125M
-
Put/Call ratio
-
0.24
-
Number of buys
-
192
-
Number of sells
-
-151
-
Price
-
$40.19
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2025
438 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q1 2025.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 351 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 135M shares
.
Largest 10 shareholders include BlackRock, Inc. (15.6M shares), VANGUARD GROUP INC (11.8M shares), FMR LLC (10.3M shares), T. Rowe Price Investment Management, Inc. (9.96M shares), WELLINGTON MANAGEMENT GROUP LLP (7.99M shares), STATE STREET CORP (6.09M shares), Deep Track Capital, LP (3.07M shares), GEODE CAPITAL MANAGEMENT, LLC (2.94M shares), RTW INVESTMENTS, LP (2.72M shares), and BANK OF AMERICA CORP /DE/ (2.7M shares).
This table shows the top 351 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.